What's hot

View all perspectives
      Lacaille et al. Long term harms of previous steroids in RA. CV/infection mortality increase 7% every year/use. Takes 3.5

      Richard Conway RichardPAConway

      9 months 2 weeks ago
      Lacaille et al. Long term harms of previous steroids in RA. CV/infection mortality increase 7% every year/use. Takes 3.5 and 10 years to return to normal after 1 and 2 years use. Never returns to normal if >2 years use @RheumNow #ACR24 Abstr#2673 #ACRbest https://t.co/qcp5mCHmeB https://t.co/keXw5Qg2ld
      All-caps abstract text throw-down by Michelle Petri re:fractures in SLE 😆

      I keep saying this; our obsesssion with v

      Mike Putman EBRheum

      9 months 2 weeks ago
      All-caps abstract text throw-down by Michelle Petri re:fractures in SLE 😆 I keep saying this; our obsesssion with vitamin d is not commensurate w/reality It's. The. Prednisone. #ACR24 @RheumNow Abstr#2679 #ACRBest https://t.co/13luByNvYT
      What are the predictors of fracture in #SLE?

      🦴Prednisone! Even at low doses ≤5mg
      🦴Stroke
      🦴Caucasian race
      ?

      Mrinalini Dey DrMiniDey

      9 months 2 weeks ago
      What are the predictors of fracture in #SLE? 🦴Prednisone! Even at low doses ≤5mg 🦴Stroke 🦴Caucasian race 🦴Female 🦴Low BMD Try to avoid steroid use. If they are needed, IM triamcinolone or IVMP preferable to oral GC. Ab2679 #ACR24 @RheumNow
      Does CVD mortality risk change after stopping GC in RA?
      ➡️28078 incident GC users
      ➡️Incr mortality risk from CVD

      Mrinalini Dey DrMiniDey

      9 months 2 weeks ago
      Does CVD mortality risk change after stopping GC in RA? ➡️28078 incident GC users ➡️Incr mortality risk from CVD &infections persists post-cessation ➡️Risk never returns to pre-GC level after prolonged use ⏩Use GC at lowest dose for shortest time possible Ab2673 #ACR24 @Rheumnow https://t.co/dtLU8obLke
      Increased risk of mortality related to negative effects of GC use persists long after stopping and never return to pre-G

      Jiha Lee JihaRheum

      9 months 2 weeks ago
      Increased risk of mortality related to negative effects of GC use persists long after stopping and never return to pre-GC levels. #GCStewardship #ACR24 @RheumNow ABST#2673 https://t.co/5AwHDmvQGf
      Ab2674 #ACR24
      ➡️Most pts starting 1st-line TNFi, who didn't achieve treatment response at 3M, also didn't achieve re

      Mrinalini Dey DrMiniDey

      9 months 2 weeks ago
      Ab2674 #ACR24 ➡️Most pts starting 1st-line TNFi, who didn't achieve treatment response at 3M, also didn't achieve response from months 3-12 ➡️1/4 pts achieving LDA/remission at 3M were no longer in LDA/remission at 12M @RheumNow https://t.co/pFOo86tJTx
      Data from the RISE registry show that 9.3% of SLE pts had thrombocytopenia and a smaller percentage with mod-severe TP (

      sheila RHEUMarampa

      9 months 2 weeks ago
      Data from the RISE registry show that 9.3% of SLE pts had thrombocytopenia and a smaller percentage with mod-severe TP (2.7%). Severe TP was much rare. Large data, but well represented grp? @RheumNow #ACR24 abs2680 https://t.co/Y1Lo9lJGtO
      An early favorable response to TNFi initiation indicates better long-term success in RA. Assess early and adjust treatme

      Jiha Lee JihaRheum

      9 months 2 weeks ago
      An early favorable response to TNFi initiation indicates better long-term success in RA. Assess early and adjust treatment accordingly. #ACR24 @RheumNow ABST#2674 https://t.co/YTThYiiLpZ
      #ACR24 BEST Abstracts from Day 1

      The RheumNow faculty have parked at the plenaries, trafficked the posters and have bee

      Dr. John Cush RheumNow

      9 months 2 weeks ago
      #ACR24 BEST Abstracts from Day 1 The RheumNow faculty have parked at the plenaries, trafficked the posters and have been finding the best the meeting offers on the first day. https://t.co/FHu616Jpyq https://t.co/oKuRcGRRAZ
      Would you trust #AI to carry out & read your #USS?

      2 systems, ARTHUR & DIANA, were comparable to that of a rheu

      Mrinalini Dey DrMiniDey

      9 months 2 weeks ago
      Would you trust #AI to carry out & read your #USS? 2 systems, ARTHUR & DIANA, were comparable to that of a rheumatologist specialising in MSK US at joint & patient levels Might this be the future of assessment in rheumatology care? AbL20 #ACR24 @RheumNow https://t.co/XtnlYafzp4
      Nailfold video capillaroscopy (NVC) allows the definite distinction between primary and secondary #Raynaud's phenomenon

      sheila RHEUMarampa

      9 months 2 weeks ago
      Nailfold video capillaroscopy (NVC) allows the definite distinction between primary and secondary #Raynaud's phenomenon and can identify early changes such as few giant capillaries &/or microhemorrages promoting early diagnosis @RheumNow #ACR24 @rheumarhyme https://t.co/Yl37w6BEZR
      Another + #SLE #RCT - large N

      #Dapirolizumab = Peg CD40L + SoC
      Vs
      #Placebo + SoC

      Rapid improvemt
      steroid sparing

      S

      Janet Pope Janetbirdope

      9 months 2 weeks ago
      Another + #SLE #RCT - large N #Dapirolizumab = Peg CD40L + SoC Vs #Placebo + SoC Rapid improvemt steroid sparing So what to use in Pts if +Ph3 👇 TYK2 Deucravacitinib JAKi Upadacitinib Dapirolizumab CAR 🚗 Rx Anifrolimumab Benlysta ETC! #ACRBest L16 @RheumNow #ACR24 https://t.co/wTFucF7BYO
      Late breaking abstract L17
      CAR-NK Therapy for Refractory SLE.
      In a trial of 20 severe SLE patients:
      - 75% achieved LLDAS

      Antoni Chan MD (Prof) synovialjoints

      9 months 2 weeks ago
      Late breaking abstract L17 CAR-NK Therapy for Refractory SLE. In a trial of 20 severe SLE patients: - 75% achieved LLDAS, 50% achieved DORIS remission at 6 months - B cell reconstitution: 2–3 months post-treatment - Safety: 2 mild cytokine release syndrome with fever; no severe… https://t.co/MS8cutm48o
      The combe-like pattern is observed in pts with APS and also in overlap syndrome
      - presence of parallel microthrombi (ora

      sheila RHEUMarampa

      9 months 2 weeks ago
      The combe-like pattern is observed in pts with APS and also in overlap syndrome - presence of parallel microthrombi (orange arrow) arranged perpendicularly, hence combe-like @RheumNow #ACR24 @rheumarhyme https://t.co/IjX7ld9lxW
      The #scleroderma-like pattern on NVC is observed in pts with #dermatomyositis and MCTD
      It consists of a combination of g

      sheila RHEUMarampa

      9 months 2 weeks ago
      The #scleroderma-like pattern on NVC is observed in pts with #dermatomyositis and MCTD It consists of a combination of giant capillaries, some microhemorrhages, severe capillary loss and angiogenesis @RheumNow #ACR24 @rheumarhyme https://t.co/WO9BOYn4ir
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Podcasts

      • ACR24 IL-17 Topic Panel Advancing Care with IL-17 Pathway Insights
      • ACR24 JAK TYK Topic Panel
      • RheumNow Day 1 Recap ACR Convergence 2024 Highlights

      Catch up on Conference Podcasts

      ×